{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:49:15Z","timestamp":1783774155094,"version":"3.55.0"},"reference-count":33,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J NeuroIntervent Surg"],"accepted":{"date-parts":[[2015,5,18]]},"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:sec>\n                  <jats:title>Background and purpose<\/jats:title>\n                  <jats:p>Thrombelastography (TEG) is widely used for the measurement of platelet function. However, few studies have investigated the TEG parameters in patients receiving extracranial or intracranial artery stenting for ischemic cerebrovascular disease. This study sought to describe the association of TEG parameters before the procedure with post-procedural ischemic events after extracranial or intracranial artery stenting.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients in whom stenting was performed for extracranial or intracranial artery stenosis (70\u201399%) were recruited into the study. Blood samples were obtained for TEG to assess platelet function before stenting. The primary endpoint was ischemic stroke or transient ischemic attack in the territory of the stented artery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 218 patients were included in the study. During a mean follow-up period of 132\u2005days (range 98\u2013226\u2005days), 18 (8.3%) primary endpoint events were recorded. Compared with patients without ischemic events, the ADP-induced platelet-fibrin clot strength (MA<jats:sub>ADP<\/jats:sub>) was significantly higher (41.57\u00b115.10 vs 33.50\u00b113.86, p=0.020) and the ADP inhibition rate (ADP%) was significantly lower in patients with ischemic events (39.54\u00b123.15 vs 55.29\u00b124.43, p=0.009). Multivariate analysis identified MA<jats:sub>ADP<\/jats:sub> and ADP% as significant independent predictors of subsequent ischemic events with HRs of 1.036 and 0.965, respectively. From receiver operating characteristic curve analysis, MA<jats:sub>ADP<\/jats:sub> &gt;49.95\u2005mm had the best predictive value of ischemic events.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our study suggests that TEG parameters MA<jats:sub>ADP<\/jats:sub> and ADP% are associated with subsequent ischemic events in patients with extracranial or intracranial stents.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical trial number<\/jats:title>\n                  <jats:p>NCT01925872.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/neurintsurg-2015-011687","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T07:32:50Z","timestamp":1433403170000},"page":"192-195","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Association of thrombelastographic parameters with post-stenting ischemic events"],"prefix":"10.1136","volume":"9","author":[{"given":"Bo","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Interventional Neuroradiology, Beijing Tian Tan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (NCRC-ND); Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Interventional Neuroradiology, Beijing Tian Tan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (NCRC-ND); Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"},{"name":"Department of Neurology, Shaanxi Provincial People's Hospital, Xi'an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Interventional Neuroradiology, Beijing Tian Tan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (NCRC-ND); Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Mo","sequence":"additional","affiliation":[{"name":"Department of Interventional Neuroradiology, Beijing Tian Tan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (NCRC-ND); Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Interventional Neuroradiology, Beijing Tian Tan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (NCRC-ND); Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Interventional Neuroradiology, Beijing Tian Tan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (NCRC-ND); Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Interventional Neuroradiology, Beijing Tian Tan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (NCRC-ND); Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Interventional Neuroradiology, Beijing Tian Tan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (NCRC-ND); Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Gang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Tian Tan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (NCRC-ND); Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Tian Tan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (NCRC-ND); Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tian Tan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (NCRC-ND); Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Rong","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Interventional Neuroradiology, Beijing Tian Tan Hospital, Capital Medical University; China National Clinical Research Center for Neurological Diseases (NCRC-ND); Center of Stroke, Beijing Institute for Brain Disorders; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,6,3]]},"reference":[{"key":"2025092912323297000_9.2.192.1","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2013.15.2.109"},{"key":"2025092912323297000_9.2.192.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061752"},{"key":"2025092912323297000_9.2.192.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708028"},{"key":"2025092912323297000_9.2.192.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912321"},{"key":"2025092912323297000_9.2.192.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.05.001"},{"key":"2025092912323297000_9.2.192.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70060-0"},{"key":"2025092912323297000_9.2.192.7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/11539580-000000000-00000","article-title":"Clopidogrel resistance is associated with long-term thrombotic events in patients implanted with drug-eluting stents","volume":"10","author":"Wang","year":"2010","journal-title":"Drugs R D"},{"key":"2025092912323297000_9.2.192.8","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.24481"},{"key":"2025092912323297000_9.2.192.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01513.x"},{"key":"2025092912323297000_9.2.192.10","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000134805.30532.59"},{"key":"2025092912323297000_9.2.192.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.10.050"},{"key":"2025092912323297000_9.2.192.12","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1111\/j.1755-5922.2010.00202.x","article-title":"Clopidogrel resistance: identifying and overcoming a barrier to effective antiplatelet treatment","volume":"29","author":"Uchiyama","year":"2011","journal-title":"Cardiovasc Ther"},{"key":"2025092912323297000_9.2.192.13","first-page":"377","article-title":"Aspirin and clopidogrel resistance: possible mechanisms and clinical relevance. Part I: Concept of resistance","volume":"65","author":"Vadasz","year":"2012","journal-title":"Ideggyogy Sz"},{"key":"2025092912323297000_9.2.192.14","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000072771.11429.83"},{"key":"2025092912323297000_9.2.192.15","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000134701.40946.30"},{"key":"2025092912323297000_9.2.192.16","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2014-011343.129"},{"key":"2025092912323297000_9.2.192.17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5603\/KP.a2014.0237","article-title":"The assessment of aspirin resistance and unstable carotid plaque among patients undergoing carotid surgery","volume":"73","author":"Lewszuk","year":"2015","journal-title":"Kardiol Pol"},{"key":"2025092912323297000_9.2.192.18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/VHRM.S9087","article-title":"Aspirin and clopidogrel resistance: methodological challenges and opportunities","volume":"6","author":"Gasparyan","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"2025092912323297000_9.2.192.19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.archger.2014.04.005","article-title":"High prevalence of aspirin resistance in elderly patients with cardiovascular disease (CVD) and hyperhomocysteinaemia","volume":"59","author":"Zhang","year":"2014","journal-title":"Arch Gerontol Geriatr"},{"key":"2025092912323297000_9.2.192.20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.thromres.2014.04.023","article-title":"Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy","volume":"134","author":"Timur","year":"2014","journal-title":"Thromb Res"},{"key":"2025092912323297000_9.2.192.21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.290"},{"key":"2025092912323297000_9.2.192.22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/09537104.2012.675108","article-title":"Usefulness of thrombelastography platelet mapping assay to measure the antiplatelet effect of P2Y(12) receptor inhibitors and high on-treatment platelet reactivity","volume":"24","author":"Jeong","year":"2013","journal-title":"Platelets"},{"key":"2025092912323297000_9.2.192.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.05.034"},{"key":"2025092912323297000_9.2.192.24","first-page":"26","article-title":"Clopidogrel resistance by P2Y12 platelet function testing in patients undergoing neuroendovascular procedures: incidence of ischemic and hemorrhagic complications","volume":"6","author":"Nordeen","year":"2013","journal-title":"J Vasc Interv Neuro"},{"key":"2025092912323297000_9.2.192.25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/00365513.2014.993696","article-title":"The relationship between on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes in Chinese patients","volume":"75","author":"Tang","year":"2015","journal-title":"Scand J Clin Lab Invest"},{"key":"2025092912323297000_9.2.192.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.12.004"},{"key":"2025092912323297000_9.2.192.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2008.02.003"},{"key":"2025092912323297000_9.2.192.28","doi-asserted-by":"publisher","DOI":"10.1583\/13-4354R.1"},{"key":"2025092912323297000_9.2.192.29","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e318286fdc8"},{"key":"2025092912323297000_9.2.192.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2005.06.031"},{"key":"2025092912323297000_9.2.192.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2009.02.008"},{"key":"2025092912323297000_9.2.192.32","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2013-010771"},{"key":"2025092912323297000_9.2.192.33","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3405"}],"container-title":["Journal of NeuroInterventional Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/neurintsurg-2015-011687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:32:40Z","timestamp":1759174360000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnis.bmj.com\/lookup\/doi\/10.1136\/neurintsurg-2015-011687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,3]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,1,13]]},"published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1136\/neurintsurg-2015-011687"],"URL":"https:\/\/doi.org\/10.1136\/neurintsurg-2015-011687","relation":{},"ISSN":["1759-8478","1759-8486"],"issn-type":[{"value":"1759-8478","type":"print"},{"value":"1759-8486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,3]]}}}